| # | Drug | Count |
|---|---|---|
| 0 | SIMVASTATIN | 113 |
| 1 | ATORVASTATIN CALCIUM | 106 |
| 2 | ATORVASTATIN CALCIUM, FILM COATED | 94 |
| 3 | ASPIRIN | 62 |
| 4 | ASPIRIN 325 MG | 62 |
| 5 | ASPIRIN 81 MG | 62 |
| 6 | METFORMIN | 60 |
| 7 | METFORMIN ER 500 MG | 60 |
| 8 | METFORMIN ER 750 MG | 60 |
| 9 | EZETIMIBE | 53 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NITAZOXANIDE | 3 | 0.0086 |
| 1 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 1 | 0.0055 |
| 2 | BENZOCAINE AND DEXTROMETHORPHAN HYDROBROMIDE | 1 | 0.0040 |
| 3 | BENZOCAINE AND MENTHOL | 1 | 0.0038 |
| 4 | AMIKACIN SULFATE | 6 | 0.0034 |
| 5 | BEMPEDOIC ACID | 9 | 0.0033 |
| 6 | CASPOFUNGIN ACETATE | 4 | 0.0025 |
| 7 | VECURONIUM BROMIDE | 3 | 0.0020 |
| 8 | RIFAPENTINE | 1 | 0.0019 |
| 9 | DOPAMINE HYDROCHLORIDE | 6 | 0.0016 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] | 9 | 0.0027 |
| 1 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 2 | Blood Viscosity Reducer [EPC] | 5 | 0.0012 |
| 3 | HMG-CoA Reductase Inhibitor [EPC] | 243 | 0.0007 |
| 4 | Dietary Cholesterol Absorption Inhibitor [EPC] | 54 | 0.0006 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 54 | 0.0005 |
| 6 | PCSK9 Inhibitor [EPC] | 13 | 0.0005 |
| 7 | Human Immunoglobulin G [EPC] | 10 | 0.0005 |
| 8 | Alkaloid [EPC] | 10 | 0.0004 |
| 9 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 21 | 0.0004 |